HIV news

• UNAIDS14 SeptUNAIDS, WHO and Unitaid bring manufacturers and governments together in Geneva as HIV financing enters a new eraFor more than 15 years, UNAIDS and WHO have convened governments, manufacturers, financing partners, communities and technical agencies in Geneva…From UNAIDS, opens their website
• i-Base11 SeptAIDS 2026: Online access now open for IAS membersFrom 9 September 2026, all IAS members will have open access to all session recordings from AIDS 2026, the 26th International AIDS Conference, held in July. Anyone who has attended any IAS conference over the last …From i-Base, opens their website
• i-Base9 SeptNew TAG 2026 pipeline reports onlineThe latest annual pipeline reports from Treatment Action Group (TAG) are now online as PDF files. treatmentactiongroup.org/resources/pipeline-report/2026-pipeline-reports/ These reports increase awareness of latest research into…From i-Base, opens their website
• UNAIDS9 SeptUNAIDS works with partners and communities to support Zambia's rollout of Lenacapavir to prevent new HIV infectionsWith Zambia having received the delivery of the first US-funded HIV prevention medicine Lenacapavir, UNAIDS is now working in close…From UNAIDS, opens their website
• i-Base9 SeptNICE fails to approve lenacapavir for HIV PrEP: will feedback lead to the right outcome in November?On 9 September 2026, the National Institute for Health and Care Excellence (NICE) announced in a 28-page report, that a ground-breaking six-monthly injection, with close to 100% efficacy against HIV transmission, will not be…From i-Base, opens their website
• BHIVA8 SeptUpdated cervical screening recommendations for people living with HIVFrom BHIVA, opens their website
• Positively UK7 SeptThe hidden food crisis facing asylum seekers living with HIVMedical education researcher and Positively UK volunteer Yiqing Wang interviews a frontline Positively UK caseworker in West London. In a West London borough, an invisible crisis is unfolding inside the temporary accommodation housing asylum seekers and…From Positively UK, opens their website
• UNAIDS4 SeptRemembering King Oyo’s heartfelt leadership for young people and the fight to end AIDSUNAIDS is deeply saddened by the passing of His Majesty King Oyo Nyimba Kabamba Iguru Rukiidi IV of the Tooro Kingdom, at a young age of 34. Imberss Fri, 09/04/2026 -…From UNAIDS, opens their website
• UNAIDS1 SeptUNAIDS condemns the destruction of lifesaving HIV supplies in UkraineUNAIDS strongly condemns the destruction of a warehouse containing HIV supplies in the region of Kyiv. The warehouse, which was destroyed on 19 July, was used by Ukraine’s National HIV…From UNAIDS, opens their website
• i-Base1 SeptFuture meetings and webinars 2026The following listing covers selected upcoming HIV-related meetings and workshops. Registration details, including for community and community press are included on the relevant websites. Some meetings are in person, some are virtual and others offer both…From i-Base, opens their website
• UNAIDS1 SeptUNAIDS, SADC and China, partner to advance local pharmaceutical manufacturing and health security in Southern AfricaUNAIDS, the Southern African Development Community (SADC) and the Global Health Innovation Institute (GHII) have brought together the…From UNAIDS, opens their website
• i-Base1 SeptMacaque study eradicates simian HIV (SHIV) with combination treatment in very early infectionAn exciting study published in the journal Nature Microbiology tentatively reports potentially curing SHIV-infected young macaques following very early treatment with a combination of immune-based therapies plus a short course of…From i-Base, opens their website
• i-Base28 AugUS FDA approves once-daily oral bictegravir/lenacapavir as simplified HIV combination (Bixlenvo)On 27 August 2026 the US FDA approved a once-daily single tablet regimen (STR) of bictegravir 75 mg/lenacapavir 50 mg as a simplification option for people currently on complex combinations. Approval was based on results from …From i-Base, opens their website
• i-Base28 AugNHS England finally approves lenacapavir for ARTAfter years of protracted discussions between NHS England and Gilead, long-acting lenacapavir injections will finally be routinely available as a life-saving drug. The indication is for people who are unable to construct an active…From i-Base, opens their website
• UNAIDS26 AugBuilt on trust - Community-led HIV responses in ThailandSitting in front of his computer, Arm, communications lead at SWING, a community-led organization providing HIV and sexual health services for gay men, transgender people and sex workers in Thailand,…From UNAIDS, opens their website
• i-Base18 AugAIDS 2026: PrEP efficacy depends on adherence not biology – PrEP access depends on politicsOne of the important plenary sessions at AIDS 2026 was on the future of HIV prevention and included an excellent review on PrEP efficacy by Raphael Landovitz from UCLA. [1] The research timeline covered results from …From i-Base, opens their website
• i-Base17 AugAIDS 2026: Free access to opening ceremony and rapporteur summariesFor the first time since COVID, the International AIDS Society (IAS) posted the opening ceremony and closing sessions as open-access live webcasts and YouTube videos for everyone to be able to watch. [1, 2] This is …From i-Base, opens their website
• i-Base17 AugAIDS 2026: The promise of bNAbs in HIV cure-related research in chronic infectionOne of the first plenary sessions at AIDS 2026 included an overview of the role of bNAbs in cure-related research. [1] The talk was given by Michel Nussenzweig from Rockefeller University, whose leading role in this …From i-Base, opens their website
• i-Base13 AugAIDS 2026: UNAIDS special report publishes data to 2025On 27 July 2026, UNAIDS released a special report for AIDS 2026, updating aggregated data on progress towards global HIV goals for 2030. Published as a set of 29 slides, the report notes that despite new …From i-Base, opens their website
• BHIVA11 Aug“Rethink. Rebuild. Rise.” – IAS 2026 reportFrom BHIVA, opens their website
• i-Base4 AugAIDS 2026: New HIV drugs in the ART pipelineAIDS 2026 included new data on the latest HIV drugs, most notably for once-weekly oral formulations and practical issues linked to treatment access. Hyperlinks in the text are to open-access abstracts but links to the webcasts …From i-Base, opens their website
• BHIVA4 AugNominate an “Unsung Hero”From BHIVA, opens their website
• i-Base27 JulAIDS 2026: Activists challenge US government’s claims to manage PEPFAROn 26 July 2026, a community protest just ahead of the International AIDS Conference highlighted the impact that the changes US funding policy have had on global health. [1] The protest was led by activists from …From i-Base, opens their website
• i-Base24 JulMerck announces alimatravir access programme ahead of AIDS 2026On 24th July 2026, a few days before the AIDS 2026 conference, US drug manufacturer Merck (known as MSD outside the US and Canada) announced plans for global access to an investigational new PrEP drug. [1] …From i-Base, opens their website
• i-Base22 JulAIDS 2026: High efficacy continues in open label extensions to lenacapavir phase 3 PrEP studiesOn 21 July 2026, still almost a week before the AIDS 2026 conference even opens, the embargo was lifted early on seven key studies at an early virtual press conference. This included results of two open-label …From i-Base, opens their website
• i-Base21 JulOne Voice Charter raises awareness of patient rights for Black people living with HIV in LondonOn 7 July 2026, the One Voices collaboration of 15 HIV organisations launched a Patient Charter to raise awareness of the rights of Black African people living with HIV in London. This Charter recognises the unique …From i-Base, opens their website
• i-Base20 JulAIDS 2026: Programme highlights to look out forThe AIDS 2026 conference is being held from 26-30 July 2026 in Rio de Janeiro with an exciting programme that is already posted online. [1] Introduction Held every two years, the International AIDS Conference organised by …From i-Base, opens their website
• BHIVA17 JulBHIVA and BASHH declare the climate emergency a health emergencyFrom BHIVA, opens their website
• BHIVA16 JulBASHH and BHIVA Joint Statement: Our commitment to supporting trans and non-binary colleagues, patients and inclusive healthcare servicesFrom BHIVA, opens their website
• i-Base13 JulBook review: Living Well with HIV: a DIY guideA new DIY guide: Living Well with HIV, now out in paperback, is a collaboration between psychologist Michael Evangeli, community activist Angelina Namiba and HIV consultant doctor Rachael Jones – each with more than 20 years …From i-Base, opens their website
• i-Base9 JulDrug interactions with islatravir (in combination with doravirine)The following information was published by the Liverpool University Drug Interaction service. In April 2026, the US Food and Drug Administration (FDA) approved a new, two-drug single-tablet regimen containing doravirine and islatravir for the treatment of…From i-Base, opens their website
• i-Base3 JulAll Wales HIV guidelines routinely exclude single tablet regimens as first-line ARTIn May 2026, new HIV prescribing guidelines were published “to support consistency across Wales in the evidence-based and prudent prescribing of ART for HIV-1”. This aims of this 13-page document include: To support doctors and…From i-Base, opens their website
• i-Base1 JulUpdated US paediatric HIV guidelines include dolutegravir from birthOn 1 July 2026, the US HHS guidelines released several updates to these important guidelines. [1] Changes to the previous guidelines cover five main sections summarised below are cross-posted from: clinicalinfo.hiv.gov Changes to…From i-Base, opens their website
• Positively UK29 JunPride in Lodnon – march with usDate: 4th July 2026 (Saturday) Time: 3:00pm Location: online Positively UK will be marching in the parade at Pride in London on Saturday 4th July, and we would love you to join us! Pride is a chance to celebrate the LGBTQ+ community, stand together in…From Positively UK, opens their website
• Positively UK29 JunSolidarity forever: Why Pride the Musical felt personalOur trustee Ant Babajee (he/him) got to watch Pride the Musical on the day of our National Conference of People Living with HIV. Reflecting for Pride Month, he writes about Mark Ashton, Jonathan Blake, HIV and trade union activism, and why this joyful story…From Positively UK, opens their website
• BHIVA26 JunEmergency Department blood-testing highlights need to extend HIV testing and raise awarenessFrom BHIVA, opens their website
• i-Base23 JunFDA and EMA applications to expand dolutegravir indication to newborns from birthOn 22 June 2026, applications were submitted to both the US FDA and European Medicines Agency (EMA) to expand the indications for dolutegravir and a paediatric formulation of dolutegravir. [1] If approved, this will provide an …From i-Base, opens their website
• Positively UK23 JunReclaiming social connexion with Positively ConnectedMedical education researcher and Positively UK volunteer Yiqing Wang sits down with Thomas Doukas, the co-leader of Positively Connected. At his very first peer support meeting, one shy participant arrived expressing deep disappointment regarding his ability…From Positively UK, opens their website
• i-Base17 JunImportant drug interactions between HIV drugs and encorafenib and dabrafenibThe June 2026 newsletter from the Liverpool Drug Interaction website includes the following new interactions between HIV drugs with encorafenib and dabrafenib. The traffic light coding uses red as contraindication, amber as…From i-Base, opens their website
• i-Base12 JunNew guidelines on persistent low-level viral load in people living with HIV (2026)New consensus guidelines on the definition and management of persistent low-level viraemia (LLV) have been developed by an international panel of more than 100 experts and are now published in Lancet HIV. [1] Recommendations were…From i-Base, opens their website
• i-Base9 JunOnce-weekly oral islatravir/lenacapavir meets 48-week primary endpoint in phase 3 studiesOn 8 June 2026, Gilead Sciences and Merck/MSD released top-line results of the phase 3 ISLEND-1 and ISLEND-2 studies using an experimental once-weekly oral formulation of islatravir 2 mg/lenacapavir 300 mg (ISL/LEN). The press…From i-Base, opens their website
• i-Base9 JunUKHSA continues to recommend 4CMenB vaccine against gonorrhoea in gay menOn 31 May 2026, UKHSA published new guidance on the continued use of the 4CMenB vaccine in a sexual health programme aimed to reduce the incidence of gonorrhoea in gay and bisexual men. [1] The guidance …From i-Base, opens their website
• i-Base9 JunCHAI reports impact of cuts in HIV, CD4 and viral load testing, reduced PrEP: children fare worstThe withdrawal of US funding for HIV treatment and prevention programmes across 14 countries in African and Asia continues to have a devastating impact according to the latest market report published in June by CHAI. [1] …From i-Base, opens their website
• BHIVA3 JunBHIVA World AIDS Day 2026 – apply for regional event funding!From BHIVA, opens their website
• i-Base1 JunBHIVA 2026: Chemsex data, service needs and how health workers can helpAlthough the complicated outcomes related to chemsex have been known within the community for at least 20 years and these led to increased development of NHS services over the last 10 years, there is still no …From i-Base, opens their website
• Positively UK28 MayNavigating the Rental Reform for Individuals Living with HIVMedical education researcher and Positively UK volunteer Yiqing Wang sits down with Hugo Rodrigues, Positively UK’s Housing Advisor, to discuss the Renters’ Rights Act and how it might affect you. On 30th April 2026, a refugee family in London faced…From Positively UK, opens their website
• BHIVA18 MayFertility clinics guidance for egg and sperm donation by people living with HIVFrom BHIVA, opens their website
• i-Base14 MayEngland’s HIV Action Plan: on target for HIV 2030 goals on preventable deaths but not for diagnoses: some key populations not includedSTOP PRESS: Please also see comment section about a second report from UKHSA published a week later to cover HIV testing. [5] Simon Collins, HIV i-Base On 14 May 2026, an impressive 48-page monitoring and evaluation report was published by …From i-Base, opens their website
• i-Base14 May6th BHIVA/BASHH Spring Conference 2026This year the BHIVA Spring Conference was organised jointly with BASHH and was attended by a record number of more than 1200 delegates and held from 27–29 April 2026 in Liverpool. The conference included more than …From i-Base, opens their website
• i-Base12 MayNew study predicts that PrEP efficacy in men is driven by drug levels in cells: matching earlier results in womenA new modelling study published as an open-access paper in Nature Communications provides further evidence that the efficacy of oral PrEP is driven by drug levels in immune cells (PBMCs), rather than levels in blood, genital …From i-Base, opens their website
• i-Base11 MayPaediatric dolutegravir/lamivudine submitted to EMA and FDA for use in younger childrenOn 11 May 2026, ViiV Healthcare announced that it had submitted applications to the European Medicines Agency (EMA) and the US FDA to extend the indications for dolutegravir/lamivudine (DTG/3TC) to younger children. The applications…From i-Base, opens their website
• BHIVA11 MayBHIVA elections 2026 – invitation to join the Executive CommitteeFrom BHIVA, opens their website
• i-Base6 MayLong-lived macrophages might explain non-suppressible low-level viraemia on ARTA paper published in April in JID proposes that macrophages could be a newly-identified source of clonally expanded HIV that could explain low-level viraemia in people who are otherwise on effective ART. [1] This is important …From i-Base, opens their website
• i-Base6 MayReview of immune-based approaches to an HIV cureAn excellent review of research using immune-based approaches to cure HIV is published as an open access article in the May 2026 issue of the journal Drugs. The challenge of finding an HIV cure currently involves …From i-Base, opens their website
• i-Base5 MayBHIVA 2026: HIV and neurodiversity includes higher concerns over adherenceResearchers from Queen Mary University London and the Share Collaborative presented results from a study on HIV and neurodivergence that was part of a large survey focussed on injectable ART. [1] The research was coproduced with …From i-Base, opens their website
• i-Base5 MayBHIVA 2026: Low engagement with sexual health clinics in NASTAL-4 surveySummary results from the latest national NASTAL-4 (National Survey of Sexual Attitudes and Lifestyles) survey reported that most people who were sexually active and at risk of STIs hadn’t visited a sexual health clinic over the …From i-Base, opens their website
• i-Base4 MayBHIVA 2026: Limited drug resistance after doxyPEP in Liverpool: uptake of 4CMenB vaccineSeveral studies at the 6th Joint BHIVA/BASHH conference presented new data from the rollout of doxyPEP to protect against syphilis and chlamydia. The first was a retrospective study of drug resistance against gonorrhoea from…From i-Base, opens their website
• i-Base4 MayBHIVA 2026: Liverpool University launches new PrEP drug interaction websiteAn essential new PrEP resource was launched at the 6th BHIVA/BASHH conference by the same team that runs the main drug interaction website at Liverpool University. https://prep-druginteractions.org. The new site is based on two main…From i-Base, opens their website
• i-Base2 MayHIV rates in transgender people in Australia drops by 94% as PrEP access increases over 10 yearsA ten year retrospective database study in Australia reported a 94% drop in HIV incidence among over 7,000 transgender and non-binary people using sexual health services, as PrEP use also significantly increased. This study also…From i-Base, opens their website
• i-Base1 MayCROI 2026: Low levels of bNAbs detected in rectal tissue up to 46 weeks post infusionLow levels of the long-acting broadly neutralising antibody (bNAb) VRC07-523LS were detected in rectal tissue of six study participants in a cure-related study. [1] Samples collected 21–51 weeks post infusion showed both penetration…From i-Base, opens their website

Headlines come from i-Base, BHIVA, Positively UK and UNAIDS. Talkpositive doesn't write or check these articles, and they aren't medical advice for you personally. Talk to your clinic about your own treatment.